First-Line Extensive-Stage Small Cell Lung Cancer: Examining the New Role of Combination Chemotherapy and Immunotherapy

Join an expert panel in thoracic oncology featuring; Kathryn Gold, MD, Taofeek Owonikoko, MD, Taofeek Owonikoko, MD, Konstantinos Leventakos, M.D., Ph.D. as they discuss how to navigate the new role of I/O therapy in combination with chemotherapy for the first-line treatment of ES-SCLC and questions surrounding how to use this approach in clinical practice.

Attend this special event to have a better understanding of:

• Characteristics of small cell lung cancer
• How SCLC and NSCLC are differentiated in clinical practice
• The need for rapid treatment response to ES-SCLC
• The role of combination chemotherapy + I/O therapy in first-line ES-SCLC
• Clinical trials for IO + chemotherapy combinations
  Standard first-line approach
• Patient involvement in treatment​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​
  ​ ​Register today
  
  
  Moderator: